相关实验视频

Updated: Jan 11, 2026

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

跨癌症的瘤-免疫接口的HOXA5-介导的空间重塑促进AML病变的发生

Changling Zhang^1,2, Ping Wen^1,2, Yan Zeng^1,2

¹Pediatric Department of Urology and Immunology, Children's Medical Center, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

Frontiers in immunology

|November 10, 2025

概括

在癌症中,Homeobox A5 (HOXA5) 具有多种作用,作为急性髓性白血病 (AML) 的预后生物标志物和免疫调节剂. 默卡波图氨酸显示出作为治疗药物重用潜力,在AML中准HOXA5.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

在癌症中Homeobox A5 (HOXA5) 的作用取决于背景,其在泛癌空间免疫和治疗潜力的功能需要进一步研究.
了解HOXA5在各种癌症类型中的空间免疫调节功能对于开发新型治疗策略至关重要.

研究的目的:

在33种癌症类型中全面分析HOXA5表达,基因组变化和免疫相互作用.
阐明HOXA5的空间免疫调节功能及其治疗潜力,特别是在急性髓性白血病 (AML) 中.

主要方法:

来自TCGA,GTEx,TISCH2和空间转录组数据集的11096个癌症和7469个正常样本的综合多组数据.
在AML细胞系 (U937,KG-1) 中对HOXA5的功能验证和计算分析,包括用于治疗标识的分子对接.

主要成果:

在所有癌症中,HOXA5表达显著失调,特别是在AML和质母细胞瘤 (GBM) 中显著升高,在乳腺癌 (BRCA) 和肺腺癌 (LUAD) 中降低.
在AML中HOXA5的高表达与生存率和特定突变 (FLT3 / NPM1) 的差异相关,空间转录组学揭示了其在纤维细胞/内皮细胞交叉中发挥的作用.
霍克萨5倒置抑制AML细胞增殖并诱导细胞循环停止;它通过胆固醇生物合成和ECM重塑维持AML. 默卡普托普林被确定为一种潜在的治疗药物.

结论:

在固体瘤和血液性恶性瘤中,HOXA5表现出不同的作用,作为一个关键的空间免疫调节器.
在AML中,HOXA5是显著的预后生物标志物和治疗点,而默卡普图普林在药物重定位方面表现有前途.

关键词:

在AML,AML就是AML.生物标志物生物标志物细胞循环中的细胞循环.细胞的增殖细胞的增殖.在hoxa5的位置上

更多相关视频

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...